Shorter, cheaper liver scans for cancer patients? small study tests new approach

NCT ID NCT04973007

Terminated Diagnosis Sponsor: University of Colorado, Denver Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared two different contrast agents used in liver MRI scans to see if a shorter, cheaper scan could work as well as the standard one for finding colorectal cancer that has spread to the liver. The trial planned to enroll 10 adults with suspected liver metastases, but it was terminated early. The goal was to save time and money without missing cancer spots.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: gadobenate dimeglumine (MultiHance) and gadoxetate disodium (Primovist/Eovist)
What this could lead to: If successful, this could make liver MRI scans faster, cheaper, and easier for patients while still finding cancer spread effectively.
What could go wrong: This was a very small, terminated study with only 10 participants, so results are limited and may not apply broadly. The approach may not be as accurate as the standard method.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER LIVER METASTASES OLIGOMETASTATIC DISEASE

Contacts and locations

Locations

University of Colorado Hospital

Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.